✦ LIBER ✦

Polymer Therapeutics Designed for a Combination Therapy of Hormone-Dependent Cancer

✍ Scribed by María J. Vicent; Francesca Greco; Robert I. Nicholson; Alison Paul; Peter C Griffiths; Ruth Duncan

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 439 KB
Volume: 117
Category: Article
ISSN: 0044-8249
DOI: 10.1002/ange.200462960

No coin nor oath required. For personal study only.

✦ Synopsis

Over the last decade, polymer therapeutics have emerged as first-generation nanomedicines. [1] The term polymer therapeutics was coined to include water-soluble polymers that are polymeric drugs, [2] hybrid polymer-drug [1, 3] and polymerprotein conjugates, [4] polymeric micelles that contain cova-

📜 SIMILAR VOLUMES

Polymer Therapeutics Designed for a Comb

Polymer Therapeutics Designed for a Combination Therapy of Hormone-Dependent Cancer

✍ María J. Vicent; Francesca Greco; Robert I. Nicholson; Alison Paul; Peter C Grif 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 439 KB

Combination hormone therapy for metastat

Combination hormone therapy for metastatic breast cancer: An ECOG study of megestrol and aminoglutethimide

✍ John Horton; Matthew Knuiman; Alan M. Keller; Harriett Vogel; Kenneth E. Gale; R 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 2 views

Response to hormonal therapy as a progno

Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapy

✍ Sewa S. Legha; Aman U. Buzdar; Terry L. Smith; Kenneth D. Swenerton; Gabriel N. 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 688 KB

Therapeutic potential of antisense Bcl-2

Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy

✍ Ryungsa Kim; Manabu Emi; Kazuaki Tanabe; Tetsuya Toge 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Macrocycles as a Tool: A Facile and One-

Macrocycles as a Tool: A Facile and One-Pot Synthesis of Silver Nanoparticles Using Cucurbituril Designed for Cancer Therapeutics

✍ Dr. Thathan Premkumar; Yeonju Lee; Prof. Dr. Kurt E. Geckeler 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 452 KB 👁 2 views

17β-hydroxysteroid dehydrogenase Type 1,

17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer

✍ Joanna M. Day; Paul A. Foster; Helena J. Tutill; Michael F.C. Parsons; Simon P. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 551 KB

## Abstract Oestradiol (E2) stimulates the growth of hormone‐dependent breast cancer. 17β‐hydroxysteroid dehydrogenases (17β‐HSDs) catalyse the pre‐receptor activation/inactivation of hormones and other substrates. 17β‐HSD1 converts oestrone (E1) to active E2, but it has recently been suggested tha